Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 14/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 13/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 13/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6740803 | 0.95 | TAS1R3 (0.45) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL10587923 | 0.88 | TAS1R3 (0.35) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL2777861 | 0.88 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL1657 | 0.84 | CES2 (0.48) | CES2CES1HTTKDM4CPKM | |
| SCHEMBL18774737 | 0.82 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL9019898 | 0.82 | TAS1R3 (0.40) | TAS1R3TAS1R1TAS1R2CES2CES1 | |
| SCHEMBL6538271 | 0.82 | CES2 (0.46) | CES2CES1HTTPKMSMN1; SMN2 | |
| SCHEMBL996758 | 0.82 | CES2 (0.43) | CES2CES1HTTPKMSMN1; SMN2 | |
| SCHEMBL19307720 | 0.79 | CES2 (0.48) | CES2CES1HTTKDM4CPKM | |
| SCHEMBL2860749 | 0.78 | TAS1R3 (0.44) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380396-B1 | CHEMICAL INTERMEDIATES FOR ANTIINFLAMMATORY AGENTS | PFIZER INC. | 2002-04-30 | — | — | US | disclosed |
| US-6207678-B1 | USED FOR TREATING INFLAMMATORY DISEASE SUCH AS ARTHRITIS, PSORIASIS, ASTHMA OR INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM DISORDER SUCH AS ANXIETY, DEPRESSION, DEMENTIA OR PSYCHOSIS, GASTROINTESTINAL DISORDERS | PFIZER INC | 2001-03-27 | — | — | US | disclosed |